Dr. Mary E. Money's Credentials

Accepting New Patients

Yes, this doctor is accepting new patients

Biography

CURRICULUM VITAE Mary E. Money, MD. FACP Name: Mary E. Money, MD, FACP Addresses: 354 Mill Street Hagerstown, MD 21740 EDUCATION: College: University of New Mexico, B.S. 1970 Honors: Phi Beta Kappa Phi Sigma Society Medical School: Medical College of Virginia, Richmond, VA Degree: Doctor of Medicine 5/18/74 Internship: Internal Medicine St. Paul-Ramsey Hospital, St. Paul, MN 6/74 – 6/75 Residency: Internal Medicine University of Minnesota Hospitals 7/75 – 6/77 University Position: Chief Resident of Internal Medicine St. Paul Ramsey Hospital 6/77 – 12/77 Clinical Associate Professor University of Maryland 7/98 – present BOARD CERTIFICATION: Board Certified by the American Board of Internal Medicine 6/22/77 no expiration SOCIETIES: American College of Physicians Medical and Chirurgical Society of State of Maryland American Diabetic Association Association of Clinical Research Professionals PRACTICES: Internist for Group Health, HMO, Minneapolis, MN 1/78 – 8/79 Private Practice, Internal Medicine, Hagerstown, MD 8/79 - present SPECIAL MEDICAL INTERESTS: Preventive Health Care Clinical Cardiology and Lipid Management Diabetes Management Patient Education Research on Association of Chronic Pancreatitis Genes and IBS-D Research on post meal diarrhea syndrome and treatment with pancreatic enzymes (multiple studies) APPOINTMENTS AND LEADERSHIP POSITIONS: Hospital Appointment and Staff Positions: Washington County Hospital Active Staff 1979 – present Medical Director for Progressive Care Unit 1991 – 2001 Medical Director for Telemetry Unit 7E 1996 – 2010 Chairperson Constitution and Bylaws Committee 1991 – 2009 Clinical Associate Professor University of Maryland 7/98 – present (Volunteer instructor for Medical Students) Washington County Special Education Task Force 1990 Washington County Hazardous Waste Committee 1991 State of Maryland Appointments: Medical Specialist of State of Maryland Hazardous Waste Management Task Force 1993 – 1995 Quality Health Care, IPA, Hagerstown, MD President and Medical Director 1995 – 1998 LECTURES: Lecturer for Washington County Hospital Association on Diabetes Repetitively for the Annual Diabetes Update for Health Care Professionals May 2002 Update in Diabetes Community Lectures in Hagerstown, MD on Advance Directives 2002 Hyperlipidemia Management for Primary Care Physicians 1998 – present University of Maryland GI Grand Rounds March 2005 University of Maryland Research Conference Oct. 2009 University of Maryland GI Grand Rounds Sept. 2010 TESTIMONY Before the Plaintiff’s Steering Committee on Aug 2009 Health Side Effects from Rosiglitazone and Communication with Smith Kline Beecham RESEARCH STUDIES: Research on Edema Associated with Rosiglitazone, Possible Association with Pulmonary Hypertension. Results submitted to Smith Kline Beecham and FDA 1999-2000 Principal Investigator for PAZAS: Effectiveness of Pancreatic Enzymes in the Reduction of Irritable Bowel Syndrome. Approved by Washington County Hospital IRB January, 2002. . Completed 11/03. Co-investigator: Incidence of “Chronic Pancreatitis- Related” Gene Mutations and Documented Malabsorp- tion among Irritable Bowel Syndrome Patients Responding to Pancreatic Enzyme Supplementation. Study Granted WCH IRB Approval 9/27/02. Primary Research Locations Hagerstown, MD and Poznam, Poland. Completed 2003. Principal Investigator: “Incidence of Chronic Pancreatitis- Related Gene Mutations Among Non-IBS Patients”. WCH IRB Approval 2/28/03. Completed 11/03. Co-investigator: “Incidence of Excessive Gastric Response and Other Reactions to Oral Food Substances Among the Adult Population”. WCH IRB Approval March 2004. Completed 11/04. Co-investigator: “Association of the Chronic Pancreatitis Genes with Intermittent Maldigestion: ? Cause of the Diarrhea Irritable Bowel Syndrome”. WCH IRB Approval March 2004. Closed Co-investigator for PAZAS II: Effectiveness of Pancreatic Enzymes in the Reduction of Irritable Bowel Syndrome. Approved by WCH IRB February, 2003. Primary Research Location Hagerstown, MD. Completed 11/03 Principal Investigator: Pilot Study: Measurement of Bile Acids and Fecal Fats in Irritable Bowel Syndrome-Diarrhea or Functional Diarrhea Patient’s Stools. Approved WCH IRB Completed. Principal Investigator: “Pilot Study: Incidence of Genetic Variations of Human Gastric Lipase, Human Pancreatic Lipases and Colipase Among Irritable Bowel Syndrome-Diarrhea Patients Compared to Controls“ Approved by WCH IRB: Closed Principal Investigator: “Pilot Study: Assessment of Gastric & Intestinal Motility following a Trigger Meal in Patients with Post Prandial Diarrhea” Approved WCH IRB: Closed Principal Investigator: “Pilot Study: Evaluation of Maldigestion in Patients with Intermittent Maldigestion Condition Compared to Controls” Approved by Meritus Medical Center IRB Closed Principal Investigator: “Pilot Study: Evaluation of Disaccharidase Concentrations in Biopsy Specimens of Patients with Unexplained Diarrhea Approved by Meritus Medical Center IRB Closed Principal Investigator: “Pilot Study: Incidence of Genetic Variations of Sucrase-Isomaltase Genes Among Patients with Postprandial Diarrhea” Approved by Meritus Medical Center IRB Feb 2012 Principal Investigator: “Pilot Study: Family Incidence of Genetic Variations of Alpha Glucosidase Genes” Approved by Meritus Medical Center IRB Feb 2012 PUBLICATIONS: Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis.Yadav D, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, Bishop MD, Baillie J, Sherman S, DiSario J, Burton FR, Gardner TB, Amann ST, Gelrud A, Lawrence C, Elinoff B, Greer JB, O'Connell M, Barmada MM, Slivka A, Whitcomb DC; North American Pancreatic Study Group.Arch Intern Med. 2009 Jun 8;169(11):1035-45.PMID: 19506173 Treatment of irritable bowel syndrome-diarrhea with pancrealipase or colesevelam and association with steatorrhea. Money ME, Hofmann AF, Hagey LR, Walkowiak J, Talley NJ.Pancreas. 2009 Mar;38(2):232-3. No abstract available. PMID: 19238028 Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2). Whitcomb DC, Yadav D, Adam S, Hawes RH, Brand RE, Anderson MA, Money ME, Banks PA, Bishop MD, Baillie J, Sherman S, DiSario J, Burton FR, Gardner TB, Amann ST, Gelrud A, Lo SK, DeMeo MT, Steinberg WM, Kochman ML, Etemad B, Forsmark CE, Elinoff B, Greer JB, O'Connell M, Lamb J, Barmada MM; North American Pancreatic Study Group. Pancreatology. 2008;8(4-5):520-31. Epub 2008 Sep 3.PMID: 18765957 The MCP-1 -2518 A/G polymorphism is not a susceptibility factor for chronic pancreatitis. Sass DA, Papachristou GI, Lamb J, Barmada MM, Brand RE, Money ME, Hawes RH, Cotton PB, Slivka A, Whitcomb DC. Pancreatology. 2006;6(4):297-300. Epub 2006 Apr 19.PMID: 16636603 Keratin 8 mutations are not associated with familial, sporadic and alcoholic pancreatitis in a population from the United States. Schneider A, Lamb J, Barmada MM, Cuneo A, Money ME, Whitcomb DC. Pancreatology. 2006;6(1-2):103-8. Epub 2005 Dec 1.PMID: 16327287 The functional angiotensin converting enzyme gene I/D polymorphism does not alter susceptibility to chronic pancreatitis. Oruc N, Lamb J, Kutlu OC, Barmada MM, Money ME, Slivka A, Whitcomb DC. JOP. 2004 Nov 10;5 (6):457-63.PMID: 15536282 Pilot Study: A randomized double blind,placebo controlled, trial of pancrealipase for the treatment of post-prandial irritable bowel syndrome- diarrhea. Money, ME, Walkowiak, J., Virgilio,C. Talley, N. Frontline Gastroenterology. Accepted September 24, 2010, Published on line 11/3/10. DOI number 10.1136/fg.2010.002253 ABO blood group and chronic pancreatitis risk in the NAPS cohort. Greer JB, LaRusch J, Brand RE, O’Connell MR, Yadav D, Whitcomb DC; NAPS2 Study Group. Pancreas. 2011 Nov;40(8); 1188-94 PMID: 21792085 Type of pain. Pain-associated complications, quality of life, disability and resource utilisation in chronic pancreatitis: a prospective cohort study. Mullady DK, Yadav D, Amann ST, O’Connell MR, Barmada MM, Elta GH, Scheiman JM, Wamsteker EJ, Chey WD, Ikorneffel ML, Weinman BM, Slivka A, Sherman S, Hawes RH, Brand RE, Burton FR, Lewis MD, Gardner TB, Gelrud A, DiSario J, Baillie J, Banks PA, Whitcomb, DC, Anderson MA; NAPS 2 Consortium. Gut. 2011 Jan;60(1): 77-84 PMID: 21148579 Review: Management of postprandial diarrhea syndrome. Money ME, Camilleri M. Am J Med. 2012 Jun;125(6):538-410.1016/j.amjmed.2011.11.006. Review. Physical and Mental Quality of Life in Chronic Pancreatitis: A Case- Control Study From the North American Pancreatitis Study 2 Cohort. Amann ST, Yadav D, Barmada MM, O'Connell M, Kennard ED, Anderson M, Baillie J, Sherman S, Romagnuolo J, Hawes RH, Alkaade S, Brand RE, Lewis MD, Gardner TB, Gelrud A, Money ME, Banks PA, Slivka A, Whitcomb DC. Pancreas. 2013 Jan 25

Education

• Va Commonwealth Univ, Med Coll Of Va Sch Of Med, Richmond Va 23298 (Grad. 1974)

Areas of Expertise

• Irritable bowel syndrome

Awards & Recognitions

• 2014 Maryland Outstanding Rural Health Practitioner
• 2015 Western Maryland Area Health Education Center Jane A. Fiscus Award

Publications & Research

• Review: Management of postprandial diarrhea syndrome. Money ME, Camilleri M. Am J Med. 2012 Jun;125(6):538-44. doi: 10.1016/j.amjmed.2011.11.006. Review. PMID: 22624684
• Pericardial diverticula misdiagnosed as pericardial cysts. Money ME, Park C. J Thorac Cardiovasc Surg. 2015 Jun;149(6):e103-7. doi: 10.1016/j.jtcvs.2015.01.032. Epub 2015 Jan 21. No abstract available. PMID: 25703410